Cargando…

EGFR, CD10 and proliferation marker Ki67 expression in ameloblastoma: possible role in local recurrence

BACKGROUND: Ameloblastoma is an odontogenic neoplasm characterized by local invasiveness and tendency towards recurrence. AIMS: Studying the role played by EGFR, CD10 and Ki67 in the recurrence of ameloblastoma. METHODS: This study was carried out on 22 retrospective cases of mandibular ameloblastom...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abdel-Aziz, Azza, Amin, Maha M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3328247/ https://www.ncbi.nlm.nih.gov/pubmed/22300665 http://dx.doi.org/10.1186/1746-1596-7-14

Ejemplares similares

P63 and Ki-67 Expression in Dentigerous Cyst and Ameloblastomas
por: Jaafari-Ashkavandi, Zohreh, et al.
Publicado: (2015)

Immunohistochemical expression of osteonectin, matrix metalloproteinases-9 and Ki-67 in ameloblastoma
por: Indirapriyadarsini, K, et al.
Publicado: (2018)

A comparative study of PCNA and Ki-67 expression in dental follicle, dentigerous cyst, unicystic ameloblastoma and ameloblastoma
por: Nafarzadeh, Shima, et al.
Publicado: (2013)

Comparison between Manual and Automated Methods for Ki-67 Immunoexpression Quantification in Ameloblastomas
por: González-González, Rogelio, et al.
Publicado: (2016)

Evaluation of the proliferation marker Ki-67 in a large prostatectomy cohort
por: Richardsen, Elin, et al.
Publicado: (2017)

Comparison of the value of PCNA and Ki-67 as markers of cell proliferation in ameloblastic tumor
por: Bologna-Molina, Ronell, et al.
Publicado: (2013)

Evaluation of the proliferation marker Ki-67 in gliomas: Interobserver variability and digital quantification
por: Nielsen, Ljudmilla A. G., et al.
Publicado: (2018)

Characterization of Cytokines and Proliferation Marker Ki67 in Cleft Affected Lip Tissue
por: Pilmane, Mara, et al.
Publicado: (2019)

A comparative immunohistochemical study of Ki-67 and Bcl-2 expression in solid ameloblastoma and adenomatoid odontogenic tumor
por: Razavi, Sayed Mohammad, et al.
Publicado: (2012)

Immunoexpression of Ki-67, MCM2, and MCM3 in Ameloblastoma and Ameloblastic Carcinoma and Their Correlations with Clinical and Histopathological Patterns
por: Carreón-Burciaga, Ramón Gil, et al.
Publicado: (2015)

CD10 and osteopontin expression in dentigerous cyst and ameloblastoma
por: Masloub, Shaimaa M, et al.
Publicado: (2011)

The Ki-67 proliferation index predicts recurrence-free survival in patients with dermatofibrosarcoma protuberans
por: Deligönül, Adem, et al.
Publicado: (2021)

Characterization of Cytokines and Proliferation Marker Ki-67 in Chronic Rhinosinusitis with Recurring Nasal Polyps
por: Viksne, Rudolfs Janis, et al.
Publicado: (2022)

Ki-67 is an independent prognostic marker for the recurrence and relapse of oral squamous cell carcinoma
por: Jing, Yue, et al.
Publicado: (2019)

Proliferating Trichilemmal Cyst: The Value Of Ki67 Immunostaining
por: Rangel-Gamboa, Lucia, et al.
Publicado: (2013)

The cell proliferation antigen Ki-67 organises heterochromatin
por: Sobecki, Michal, et al.
Publicado: (2016)

Ki-67, an elusive marker in the prognosis of breast cancer
por: Sood, Neelam
Publicado: (2019)

A Comparison of Ki67, Syndecan-1 (CD138), and Molecular RANK, RANKL, and OPG Triad Expression in Odontogenic Keratocyts, Unicystic Ameloblastoma, and Dentigerous Cysts
por: Brito-Mendoza, Luisana, et al.
Publicado: (2018)

Immunohistochemical study of the expression of alpha-smooth muscle actin and the proliferation marker Ki-67 of glomerulonephritis.
por: Kim, O.
Publicado: (2001)

The value of the FDG-GaTate and proliferation marker (ki-67) in the assessment of neuroendocrine tumours (NETs)
por: Fikri, AS Fathinul, et al.
Publicado: (2015)

Adult WHO grade II ependymomas: is Ki67 a sex-specific proliferation marker?
por: Baig Mirza, Asfand, et al.
Publicado: (2021)

Proliferation Marker Ki67 as a Stratification Index of Adjuvant Chemotherapy for Resectable Mucosal Melanoma
por: Tang, Lirui, et al.
Publicado: (2022)

Recurrence of Pancreatic Neuroendocrine Tumors and Survival Predicted by Ki67
por: Genç, C. G., et al.
Publicado: (2018)

Utility of Serum Ki-67 as a Marker for Malignancy in Dogs
por: Estaller, Annkathrin, et al.
Publicado: (2022)

Synovial sarcoma. Evaluation of Prognosis with Emphasis on the Study of DNA Ploidy and Proliferation (PCNA and Ki-67) Markers
por: M. Lopes, José, et al.
Publicado: (1998)

Characterization of Cytokines and Proliferation Marker Ki67 in Chronic Rhinosinusitis with Nasal Polyps: A Pilot Study
por: Viksne, Rudolfs Janis, et al.
Publicado: (2021)

Digital Image Analysis of the Proliferation Markers Ki67 and Phosphohistone H3 in Gastroenteropancreatic Neuroendocrine Neoplasms: Accuracy of Grading Compared With Routine Manual Hot Spot Evaluation of the Ki67 Index
por: Lea, Dordi, et al.
Publicado: (2021)

Ki-67 gene expression
por: Uxa, Sigrid, et al.
Publicado: (2021)

Ki-67 is required for maintenance of cancer stem cells but not cell proliferation
por: Cidado, Justin, et al.
Publicado: (2016)

Diagnostic and Prognostic Value Of Ki67 Proliferation Fraction in Serous Effusions
por: Schönherr, Alexandra, et al.
Publicado: (2004)

IHC Color Histograms for Unsupervised Ki67 Proliferation Index Calculation
por: Geread, Rokshana S., et al.
Publicado: (2019)

Ki67 as a prognostic factor of craniopharyngioma’s recurrence in paediatric population
por: Moszczyńska, Elżbieta, et al.
Publicado: (2020)

To Ki or Not to Ki: Re-Evaluating the Use and Potentials of Ki-67 for T Cell Analysis
por: Di Rosa, Francesca, et al.
Publicado: (2021)

67. INCREASED RISK OF BREAST CANCER BRAIN METASTASIS WITH EGFR AND Ki-67 EXPRESSION: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: Job, Arun, et al.
Publicado: (2020)

The Ki67 index a prognostic marker in medullary thyroid carcinoma
por: Tisell, L E, et al.
Publicado: (2003)

Ki-67 is a prognostic marker for hormone receptor positive tumors
por: Pérez-López, M. E., et al.
Publicado: (2016)

MCM - 2 and Ki - 67 as proliferation markers in renal cell carcinoma: A quantitative and semi - quantitative analysis
por: Mehdi, Muhammad Zain, et al.
Publicado: (2016)

The proliferation marker Ki67, but not neuroendocrine expression, is an independent factor in the prediction of prognosis of primary prostate cancer patients
por: Pascale, Mariarosa, et al.
Publicado: (2016)

Correlation of Ki-67 Expression as Tumor cell Proliferation Activity Marker with Cutaneous Squamous Cell Carcinoma Grading
por: Alferraly, Ibnu T., et al.
Publicado: (2019)

Assessment of Ki67 in Breast Cancer: A Comparison Between the Eye-10 Method, Stepwise Counting Strategy, and International System of Ki67 Evaluation
por: Kadivar, Maryam, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_c14896uifc06t13occrr1not37